These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7728271)

  • 1. Safety monitoring and epidemiological surveillance of blood transfusion in the United States.
    Menache D; O'Malley JP
    Transfus Clin Biol; 1995; 2(1):7-12. PubMed ID: 7728271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety monitoring and epidemiological surveillance of blood transfusion in Europe.
    Van Aken WG
    Transfus Clin Biol; 1995; 2(1):13-5. PubMed ID: 7728264
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood safety. The Food and Drug Administration's role.
    Gustafson M
    Arch Pathol Lab Med; 1999 Jun; 123(6):475-7. PubMed ID: 10383796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current good manufacturing practices.
    Zuck TF
    Transfusion; 1995; 35(11):955-66. PubMed ID: 8604495
    [No Abstract]   [Full Text] [Related]  

  • 5. 100 years of biologics regulation.
    FDA Consum; 2002; 36(4):8-10. PubMed ID: 12184315
    [No Abstract]   [Full Text] [Related]  

  • 6. It's in the bag! (or is it?).
    Taswell HF
    Transfusion; 1991 Jun; 31(5):386-7. PubMed ID: 2048173
    [No Abstract]   [Full Text] [Related]  

  • 7. Virus inactivation of fresh plasma.
    Mohr H
    Vox Sang; 1998; 74 Suppl 2():171-2. PubMed ID: 9704442
    [No Abstract]   [Full Text] [Related]  

  • 8. The transmissible spongiform encephalopathy agents: concerns and responses of United States regulatory agencies in maintaining the safety of biologics.
    Asher DM
    Dev Biol Stand; 1999; 100():103-18. PubMed ID: 10616181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemovigilance in the United States of America.
    Menitove JE
    Vox Sang; 1998; 74 Suppl 2():447-55. PubMed ID: 9704480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule.
    Fed Regist; 1996 Sep; 61(175):47413-23. PubMed ID: 10160337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The European network of transfusion medicine societies (EuroNet-TMS): The White Book 2005].
    Rouger P
    Transfus Clin Biol; 2005 Jun; 12(2):83-92. PubMed ID: 15896994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Viral safety concept: application to blood and blood products].
    Trouvin JH
    Rev Prat; 2005 Nov; 55(18):2033-8. PubMed ID: 16419908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The history of regulatory system for plasma fractionation products in the United States].
    Fukuzawa M; Tsutani K
    Yakushigaku Zasshi; 2014; 49(2):205-13. PubMed ID: 25799842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How do we implement Day 6 and Day 7 platelets at a hospital-based transfusion service?
    Dunbar NM; Dumont LJ; Szczepiorkowski ZM
    Transfusion; 2016 Jun; 56(6):1262-6. PubMed ID: 27018564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiological safety of blood transfusion.
    Barbara JA
    Vox Sang; 1998; 74 Suppl 2():11-3. PubMed ID: 9704421
    [No Abstract]   [Full Text] [Related]  

  • 16. [The sterility of blood products manufactured in Ukraine].
    Liubich VV
    Lik Sprava; 1992 Feb; (2):57-60. PubMed ID: 1441334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality control and transfusion reactions.
    Beal RW
    Anaesth Intensive Care; 1980 May; 8(2):172-7. PubMed ID: 6772054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oversight and monitoring of blood safety in the United States.
    Busch M; Chamberland M; Epstein J; Kleinman S; Khabbaz R; Nemo G
    Vox Sang; 1999; 77(2):67-76. PubMed ID: 10516550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paid-versus-volunteer blood donation in the United States: a historical review.
    Domen RE
    Transfus Med Rev; 1995 Jan; 9(1):53-9. PubMed ID: 7719038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The International Haemovigilance Network Database for the Surveillance of Adverse Reactions and Events in Donors and Recipients of Blood Components: technical issues and results.
    Politis C; Wiersum JC; Richardson C; Robillard P; Jorgensen J; Renaudier P; Faber JC; Wood EM
    Vox Sang; 2016 Nov; 111(4):409-417. PubMed ID: 27658188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.